EP2934494B1 - Pharmaceutical Formulation of N- [5- [2-(3,5-Dimethoxyphenyl) Ethyl]-2h-Pyrazol-3-Yl]-4-[(3r,5s)-3,5-Dimethylpiperazin-1-Yl]benzamide